Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.210 | 3.210 | 0.000 |
Stocks | 96.790 | 96.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.119 | 23.756 |
Price to Book | 10.284 | 4.632 |
Price to Sales | 5.423 | 3.427 |
Price to Cash Flow | 22.968 | 16.566 |
Dividend Yield | 1.382 | 1.248 |
5 Years Earnings Growth | 9.992 | 13.206 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.950 | 16.034 |
Consumer Defensive | 31.600 | 7.346 |
Technology | 12.830 | 27.345 |
Financial Services | 9.210 | 13.719 |
Consumer Cyclical | 8.150 | 12.372 |
Industrials | 6.260 | 12.000 |
Number of long holdings: 25
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
L'Oreal | FR0000120321 | 5.74 | 329.80 | +0.87% | |
Intuit | US4612021034 | 5.08 | 705.00 | -0.18% | |
Waters | US9418481035 | 4.88 | 381.65 | -1.03% | |
Microsoft | US5949181045 | 4.79 | 427.55 | +0.55% | |
Visa A | US92826C8394 | 4.58 | 309.01 | -0.15% | |
Novo Nordisk A/S Class B | DK0060534915 | 4.52 | - | - | |
Stryker | US8636671013 | 4.48 | 389.72 | +0.36% | |
Church&Dwight | US1713401024 | 4.48 | 108.06 | +0.75% | |
PayPal | US70450Y1038 | 4.33 | 85.81 | -1.72% | |
J&J | US4781601046 | 4.33 | 152.68 | -0.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 14.27B | 7.19 | 3.42 | 14.76 | ||
Fundsmith Equity I Inc | 4.23B | 7.19 | 3.42 | 14.75 | ||
Fundsmith Equity R Acc | 595M | 6.71 | 2.80 | 14.06 | ||
Fundsmith Equity R Inc | 15.75M | 6.70 | 2.80 | 14.06 | ||
Fundsmith Equity T Acc | 3.97B | 7.11 | 3.32 | 14.64 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review